Category: News Well
Content tagged to appear in the middle column of the home page
Troubled Intuitive Surgical manages to blow away Wall Street's expectations, even as Q2 profits drop 35% year-over-year.
California device maker Intuitive Surgical (NSDQ:ISRG) got a major after-hours boost after reporting Q2 numbers that, while still down year-over-year, beat Wall Street's expectations by a mile.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
The Centers for Medicare & Medicaid Services proposes 4 changes to physician payment transparency rules that could mean major new costs for medical device makers.
Medicare regulators are looking for feedback on proposed changes to the laws governing transparency in financial relationships between doctors and healthcare companies, warning that the changes may represent a hefty new cost for medical device makers in particular.
Doctors checking a soon-to-be-unveiled federal website that will publicly list drug company payments are encountering error messages if they have not accepted industry money.
by Charles Ornstein, ProPublica
The federal government has a word for physicians who don't have financial relationships with pharmaceutical and medical device manufacturers: "Error."
A $7 million funding round for Cardiac Insight, 1st reported by MassDevice.com, was led by Welch Allyn and includes exclusive global distribution rights, the companies said yesterday.
The Massachusetts medtech giant launches commercial efforts for its Polaris imaging software, an upgrade to the iLab system that aims to be "smart, fast and accurate."
Boston Scientific (NYSE:BSX) today announced the commercial launch of its Polaris imaging software, an upgrade to the company's iLab system that aims to make intravascular imaging simpler and more powerful.
The U.S. Securities & Exchange Commission dings an outside investor relations executive for Misonix with insider trading charges.
The U.S. Securities & Exchange Commission today dinged an outside investor relations executive with insider trading charges, accusing Kevin McGrath of Cameron Assoc. of "trading on confidential information he learned about two clients while he helped prepare their press releases."